VOLNEWMER
Skin firmness. A focus on you.
A monopolar radiofrequency system for controlled dermal heating and skin tightening. Continuous water cooling, impedance monitoring and four tip sizes support treatment of different face and body areas.
Your medical assessment determines suitability.
Understand the platform.
6.78 MHz monopolar radiofrequency
- 016.78 MHz monopolar RF
- 02Continuous water cooling & impedance monitoring
- 03Four tips: 0.25, 3, 4 & 16 cm²
Areas of application
Facial skin laxity · Jawline & neck firmness · Body skin tightening
An informed choice.
What the evidence can tell you — and where its limits matter.
Sources checkedEvidence & expectations
A systematic review found measurable laxity improvements with monopolar and bipolar RF across several devices. Techniques, study designs and follow-up varied. These findings do not prove that different platforms are equivalent or that RF reproduces a surgical lift.[1]
Preparation & recovery
Discuss implants, previous procedures and any condition affecting the treatment area. Ask what sensations and visible changes to expect, and how the proposed applicator determines recovery and follow-up.[2]
Risks & limitations
Energy-based procedures can cause pain, swelling, burns or unwanted tissue effects. Eligibility and risks depend on the modality and body site. Non-invasive does not mean risk-free or equivalent to surgery.[2]
Compare your options
Discuss whether the main issue is laxity, volume, muscle movement or a surface change. Ultrasound, injectables and laser treatments target different structures; a combined plan should explain the added purpose and burden of each step.[1]
Different approaches to discuss
These links explain different targets. They are not personalised recommendations.
K-LUXEUltraformer MPT ultrasound liftingSources & further reading
- Systematic reviewMonopolar and bipolar radiofrequency for skin tightening: systematic reviewRohrich et al. · Plastic and Reconstructive Surgery · 2022
- Regulatory safety informationNon-invasive body contouring technologiesFDA
- Manufacturer informationVOLNEWMER: platform informationClassysManufacturer information explains the platform or named protocol; it is not independent evidence of clinical benefit.
How we use evidence
A controlled trial compares interventions in defined groups; an uncontrolled cohort cannot, alone, establish causality. A review depends on the quality of its included studies. We distinguish these sources from manufacturer information and identify when findings do not directly apply to the platform or protocol.
The date records when sources were checked for this guide. It is not a statement of individual clinical review, product authorisation or confirmation of the clinic’s available configuration.
This guide supports a conversation with your clinician. It does not determine your suitability or replace individual aftercare instructions.
Regulatory sources describe their own jurisdictions; a US authorisation or warning does not determine a product’s legal status in Portugal.
Related technologies
XERFDual-frequency monopolar RF
ApexRFBipolar RF & muscle stimulation platform
EmpowerRFRadiofrequency & electrical muscle stimulation